CryoLife Inc (CRY) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 19.60 High: 20.26

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Market capMarket cap information

    $703 Mln

  • Revenue (TTM)Revenue (TTM) information

    $305 Mln

  • Net Profit (TTM)Net Profit (TTM) information

    $-15 Mln

  • ROEROE information

    0 %

  • ROCEROCE information

    -- %

  • P/E RatioP/E Ratio information

    425.7

  • P/B RatioP/B Ratio information

    2.2

  • Industry P/EIndustry P/E information

    54.26

  • EV/EBITDAEV/EBITDA information

    22.5

  • Div. YieldDiv. Yield information

    0.2 %

  • Debt to EquityDebt to Equity information

    1

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    39,329,600

10 Years Aggregate

CFO

$121.34 Mln

EBITDA

$230.41 Mln

Net Profit

$17.29 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
CryoLife Inc (CRY)
-0.5 9.8 -0.5 -9.9 -10.4 3.9 15.0
BSE Sensex*
-13.4 -9.8 -13.9 -3.6 7.5 7.9 11.2
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 24-Mar-2022  |  *As on 02-Apr-2026  |  #As on 26-Oct-2023
Company
2021
2020
2019
2018
2017
2016
2015
CryoLife Inc (CRY)
-13.8 -12.8 -4.5 47.9 0.0 77.6 -3.8
S&P Small-Cap 600
25.3 9.6 20.9 -9.7 11.7 24.7 -3.4
BSE Sensex
22.0 15.8 14.4 5.9 27.9 1.9 -5.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
CryoLife Inc (CRY)
20.3 703.2 305.0 -15.1 1.3 -5 425.7 2.2
0.1 -- 92.8 -69.0 -70.2 -- -- 0.0

Shareholding Pattern

View Details
loading...

About CryoLife Inc (CRY)

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary,...  and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. Artivion Inc. was founded   Read more

  • Chairman, Pres & CEO

    Mr. James Patrick Mackin

  • Exec. VP, COO & CFO

    Mr. David Ashley Lee CPA, CPA

  • Headquarters

    Kennesaw, GA

  • Website

    https://artivion.com

Edit peer-selector-edit
loading...
loading...

FAQs for CryoLife Inc (CRY)

The share price of CryoLife Inc (CRY) is $20.25 (NYSE) as of 24-Mar-2022 09:30 EDT. CryoLife Inc (CRY) has given a return of -10.36% in the last 3 years.

The P/E ratio of CryoLife Inc (CRY) is 425.71 times as on 24-Mar-2022, a 685 premium to its peers’ median range of 54.26 times.
The P/B ratio of CryoLife Inc (CRY) is 2.22 times as on 24-Mar-2022, a 25 discount to its peers’ median range of 2.95 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2021
--
--
2020
--
--
2019
--
--
2018
--
--
2017
--
--

The 52-week high and low of CryoLife Inc (CRY) are Rs -- and Rs -- as of 02-Apr-2026.

CryoLife Inc (CRY) has a market capitalisation of $ 703 Mln as on 24-Mar-2022. As per SEBI classification, it is a Small Cap company.

Before investing in CryoLife Inc (CRY), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.